Search research articles
Contact Us
Filters
Showing results (631-640 of 1,920) with videos related to
Page
of 192
Sort By:
RMD Open
|
February 27, 2018
From patients with arthralgia, pre-RA and recently diagnosed RA: what is the current status of understanding RA pathogenesis?
Marlieke Molendijk, Johanna Mw Hazes, Erik Lubberts
RMD Open
|
June 23, 2022
Meaning of patient global assessment when joint counts are low in rheumatoid arthritis
David Felson, Vivi Feathers, Chinmayi Naik, et al.
RMD Open
|
July 7, 2022
Impact of apremilast on quality of life in Behçet's syndrome: analysis of the phase 3 RELIEF study
Gülen Hatemi, Alfred Mahr, Mitsuhiro Takeno, et al.
RMD Open
|
June 14, 2022
Pollutants: a candidate as a new risk factor for osteoarthritis-results from a systematic literature review
Camille Deprouw, Alice Courties, Jean-Baptiste Fini, et al.
RMD Open
|
June 14, 2022
Improved patient-reported outcomes in patients with psoriatic arthritis treated with risankizumab: analysis of the Phase 3 trial KEEPsAKE 2
Andrew J K Ostor, Ahmed M Soliman, Kim A Papp, et al.
RMD Open
|
June 14, 2022
High prevalence of chondrocalcinosis and frequent comorbidity with calcium pyrophosphate deposition disease in patients with seronegative rheumatoid arthritis
Martin Krekeler, Xenofon Baraliakos, Styliani Tsiami, et al.
RMD Open
|
June 15, 2022
Active counselling and well-controlled disease result in a higher percentage of women with rheumatoid arthritis that breast feed: results from the PreCARA study
Erik Kemper, Nafise Ghalandari, Hetty Wintjes, et al.
RMD Open
|
July 6, 2022
Is the Rheumatoid Arthritis Impact of Disease (RAID) score a meaningful instrument for other inflammatory rheumatic diseases? A cross-sectional analysis of data from the German National Database
Katja Thiele, Katinka Albrecht, Angela Zink, et al.
RMD Open
|
June 8, 2021
Treatment journey in rheumatoid arthritis with biosimilars: from better access to good disease control through cost savings and prevention of nocebo effects
Josef S Smolen, Roberto Caporali, Thomas Doerner, et al.
RMD Open
|
June 1, 2021
New risk model is able to identify patients with a low risk of progression in systemic sclerosis
Nina Marijn van Leeuwen, Marc Maurits, Sophie Liem, et al.
Page
of 192
Search research articles
Search
Showing results (631-640 of 1,920) with videos related to
Sort By:
Page
of 192
RMD Open
|
February 27, 2018
From patients with arthralgia, pre-RA and recently diagnosed RA: what is the current status of understanding RA pathogenesis?
Marlieke Molendijk, Johanna Mw Hazes, Erik Lubberts
RMD Open
|
June 23, 2022
Meaning of patient global assessment when joint counts are low in rheumatoid arthritis
David Felson, Vivi Feathers, Chinmayi Naik, et al.
RMD Open
|
July 7, 2022
Impact of apremilast on quality of life in Behçet's syndrome: analysis of the phase 3 RELIEF study
Gülen Hatemi, Alfred Mahr, Mitsuhiro Takeno, et al.
RMD Open
|
June 14, 2022
Pollutants: a candidate as a new risk factor for osteoarthritis-results from a systematic literature review
Camille Deprouw, Alice Courties, Jean-Baptiste Fini, et al.
RMD Open
|
June 14, 2022
Improved patient-reported outcomes in patients with psoriatic arthritis treated with risankizumab: analysis of the Phase 3 trial KEEPsAKE 2
Andrew J K Ostor, Ahmed M Soliman, Kim A Papp, et al.
RMD Open
|
June 14, 2022
High prevalence of chondrocalcinosis and frequent comorbidity with calcium pyrophosphate deposition disease in patients with seronegative rheumatoid arthritis
Martin Krekeler, Xenofon Baraliakos, Styliani Tsiami, et al.
RMD Open
|
June 15, 2022
Active counselling and well-controlled disease result in a higher percentage of women with rheumatoid arthritis that breast feed: results from the PreCARA study
Erik Kemper, Nafise Ghalandari, Hetty Wintjes, et al.
RMD Open
|
July 6, 2022
Is the Rheumatoid Arthritis Impact of Disease (RAID) score a meaningful instrument for other inflammatory rheumatic diseases? A cross-sectional analysis of data from the German National Database
Katja Thiele, Katinka Albrecht, Angela Zink, et al.
RMD Open
|
June 8, 2021
Treatment journey in rheumatoid arthritis with biosimilars: from better access to good disease control through cost savings and prevention of nocebo effects
Josef S Smolen, Roberto Caporali, Thomas Doerner, et al.
RMD Open
|
June 1, 2021
New risk model is able to identify patients with a low risk of progression in systemic sclerosis
Nina Marijn van Leeuwen, Marc Maurits, Sophie Liem, et al.
Page
of 192